PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led ‘as-needed’ treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis

by | Oct 10, 2025

PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led ‘as-needed’ treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis

Ye, C., Powell, K., Dooley, N., Thomas, C., Coker, B., McAteer, H., Wei, J. R., Tan, W. R., Baudry, D., Dasandi, T., Pizzato, J., Sach, T. H., Gregory, J., Yang, Z., Pink, A., Woolf, R., Warren, R. B., Weinman, J., Barker, J. & Chapman, S. & 4 others, Standing, J. F., Norton, S., Smith, C. & Mahil, S., 10 Oct 2025, BMJ and BMJ Publishing.

Research output: Other contribution